Clinical Briefs

Kuritzky, Louis
January 2011
Internal Medicine Alert;1/29/2011 Clinical Briefs, p16
The article offers medical updates in the U.S. including one about a study on how to treat type 2 diabetes (DM2) and a study that suggests that familial component contributes to atrial fibrillation (a-FIB).


Related Articles

  • Education: Journals Club - Atrial fibrillation and antithrombotic treatment. Newson, Louise // GP: General Practitioner;3/12/2010, p53 

    The article lists several research findings published in various journals on topics related to atrial fibrillation (AF), including beta-blockers in treatment of AF patients, use of oral anticoagulation agents in AF patients, and use of warfarin to prevent stroke in AF patients.

  • Excessive supraventricular arrhythmias linked with poor prognosis for death, stroke.  // Cardiology Today;Jun2010, Vol. 13 Issue 6, p23 

    The article delves into a study about the link between excessive supraventricular ectopic activity and development of atrial fibrillation (AF) in healthy patients, published in an issue of "Circulation."

  • Erythrocyte Aggregation in Nonvalvular Atrial Fibrillation. Caimi, Gregorio; Messina, Luigi // Clinical & Applied Thrombosis/Hemostasis;Jan2001, Vol. 7 Issue 1, p75 

    A letter to the editor is presented in response to the article "Erythrocyte Aggregation in Nonvalvular Atrial Fibrillation."

  • Efficacy of apixaban as compared with warfarin in relation to renal function in patients with atrial fibrillation - Insights from the ARISTOTLE Trial. Hohnloser, Stefan H. // Cardiologia Croatica;2012, Vol. 7 Issue 9/10, Special section p1 

    The article provides information on the study "Efficacy of apixaban as compared with warfarin in relation to renal function in patients with atrial fibrillation--Insights from the ARISTOTLE Trial," by Stefan H. Hohnloser.

  • Lenient vs Strict Rate Control in Patients with AF. DiMarco, John A. // Internal Medicine Alert;5/15/2010, Vol. 32 Issue 9, p68 

    The article presents a comparison between lenient and strict rate controls in patients with recent onset Aterial Fibrilation.

  • RE-LY: low risk of intracranial haemorrhage with dabigatran.  // Reactions Weekly;5/19/2012, Issue 1402, p3 

    The article discusses research study being done on the link between dabigatran etexilate and risk of intracranial hemorrhage in patients with atrial fibrillation (AF), referencing a study by R. G. Hart et al., published in the April 5, 2012 issue of "Stroke."

  • Diabetes may be independent risk factor for atrial fibrillation. Blazek, Nicole; Brannon, Matthew; Harris, Jason; Kalvaitis, Katie; Southall, Jennifer // Endocrine Today;Jun2010, Vol. 8 Issue 6, p33 

    The article presents information about a study linking patients with diabetes to the risk for developing atrial fibrillation, published in an issue of "Journal of General Internal Medicine."

  • Aiming for greater use of anticoagulants in AF.  // PharmacoEconomics & Outcomes News;Dec2014, Vol. 717 Issue 1, p15 

    The article discusses research being done on atrial fibrillation (AF), referencing the study "The Move Towards Full Implementation of the Nice Guidelines for Stroke Prevention in Atrial Fibrillation: The Potential Cost and Clinical Impact" by G. E. Shields and colleagues presented at the 17th...

  • Diagnosis and Therapy of Atrial Fibrillation: the Past, the Present and the Future. van Marion, Denise M. S.; Lanters, Eva A. H.; Wiersma, Marit; Allessie, Maurits A.; Brundel, Bianca B. J. J. M.; de Groot, Natasja M. S. // JAFIB: Journal of Atrial Fibrillation;Aug/Sep2015, Vol. 8 Issue 2, p51 

    Atrial fibrillation (AF) is the most common age-related cardiac arrhythmia. It is a progressive disease, which hampers successful treatment. The progression of AF is caused by the accumulation of damage in cardiomyocytes which makes the atria more vulnerable for AF. Especially structural...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics